Artículo
A DNA vaccine encoding the enterohemorragic Escherichia coli shiga-like toxin 2 A2 and B subunits confers protective immunity to shiga toxin challenge in the murine model
Bentancor, Leticia Verónica
; Bilen, Marcos Fabian
; Fernández Brando, Romina Jimena
; Ramos, Maria Victoria
; Ferreira, Luis C. S.; Ghiringhelli, Pablo Daniel
; Palermo, Marina Sandra
![Icon](/themes/CONICETDigital/images/conicet.png)
![Icon](/themes/CONICETDigital/images/conicet.png)
![Icon](/themes/CONICETDigital/images/conicet.png)
![Icon](/themes/CONICETDigital/images/conicet.png)
![Icon](/themes/CONICETDigital/images/conicet.png)
![Icon](/themes/CONICETDigital/images/conicet.png)
Fecha de publicación:
05/2009
Editorial:
American Society for Microbiology
Revista:
Clinical and Vaccine Immunology
ISSN:
1556-6811
Idioma:
Inglés
Tipo de recurso:
Artículo publicado
Clasificación temática:
Resumen
Production of verocytotoxin or Shiga-like toxin (Stx), particularly Stx2, is the basis of hemolytic uremic syndrome, a frequently lethal outcome for subjects infected with Stx2-producing enterohemorrhagic Escherichia coli (EHEC) strains. The toxin is formed by a single A subunit, which promotes protein synthesis inhibition in eukaryotic cells, and five B subunits, which bind to globotriaosylceramide at the surface of host cells. Host enzymes cleave the A subunit into the A1 peptide, endowed with N-glycosidase activity to the 28S rRNA, and the A2 peptide, which confers stability to the B pentamer. We report the construction of a DNA vaccine (pStx2ΔAB) that expresses a nontoxic Stx2 mutated form consisting of the last 32 amino acids of the A2 sequence and the complete B subunit as two nonfused polypeptides. Immunization trials carried out with the DNA vaccine in BALB/c mice, alone or in combination with another DNA vaccine encoding granulocyte- macrophage colony-stimulating factor, resulted in systemic Stx-specific antibody responses targeting both A and B subunits of the native Stx2. Moreover, anti-Stx2 antibodies raised in mice immunized with pStx2AAB showed toxin neutralization activity in vitro and, more importantly, conferred partial protection to Stx2 challenge in vivo. The present vector represents the second DNA vaccine so far reported to induce protective immunity to Stx2 and may contribute, either alone or in combination with other procedures, to the development of prophylactic or therapeutic interventions aiming to ameliorate EHEC infection-associated sequelae. Copyright © 2009, American Society for Microbiology. All Rights Reserved.
Archivos asociados
Licencia
Identificadores
Colecciones
Articulos(SEDE CENTRAL)
Articulos de SEDE CENTRAL
Articulos de SEDE CENTRAL
Citación
Bentancor, Leticia Verónica; Bilen, Marcos Fabian; Fernández Brando, Romina Jimena; Ramos, Maria Victoria; Ferreira, Luis C. S.; et al.; A DNA vaccine encoding the enterohemorragic Escherichia coli shiga-like toxin 2 A2 and B subunits confers protective immunity to shiga toxin challenge in the murine model; American Society for Microbiology; Clinical and Vaccine Immunology; 16; 5; 5-2009; 712-718
Compartir
Altmétricas